Urinary Sex Steroid Metabolites: How Training and Exercise Change Your Results

What Are Urinary Sex Steroid Metabolites?

Urinary sex steroid metabolites are the downstream breakdown products of estrogens, androgens, and their precursors, collected in urine and measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The panel captures not just total estrogen load but the specific enzymatic routes the body used to inactivate and excrete hormones. Those routes matter because different metabolites carry different biological activity.

The core estrogen metabolites measured are estrone (E1), estradiol (E2), estriol (E3), and their hydroxylated and methylated daughters: 2-hydroxyestrone (2-OHE1), 4-hydroxyestrone (4-OHE1), 16-alpha-hydroxyestrone (16-OHE1), 2-methoxyestrone (2-MeOE1), and 2-hydroxyestradiol (2-OHE2). Androgen metabolites on the same panel typically include testosterone glucuronide, DHEA-S, androsterone, etiocholanolone, and 5-alpha-androstanediol glucuronide.

Why the Hydroxylation Route Matters

The 2-OH pathway, driven primarily by CYP1A1 and CYP1A2, generates catechol estrogens that bind the estrogen receptor weakly and are rapidly methylated to inert 2-MeOE1 by catechol-O-methyltransferase (COMT). The 16-OH pathway generates 16-OHE1, which binds the estrogen receptor with high affinity and stimulates cell proliferation [1]. The 4-OH pathway produces electrophilic quinones capable of forming DNA adducts [2].

The 2-OHE1:16-OHE1 Ratio as a Clinical Marker

Observational evidence from the Nurses' Health Study and the European Prospective Investigation into Cancer (EPIC) cohort has linked higher 2-OHE1:16-OHE1 ratios to lower breast tissue proliferation risk [3]. A ratio greater than 2.0 is the threshold most commonly cited in functional and integrative medicine guidelines, though no randomized controlled trial has yet used this ratio as a primary cardiovascular or oncologic endpoint [4].

How Exercise Shifts Estrogen Metabolism

Aerobic exercise raises the 2-OHE1:16-OHE1 ratio through at least three parallel mechanisms: reducing adipose aromatase output, upregulating hepatic CYP1A1 activity, and improving COMT methylation efficiency via better methylation cofactor status. Each mechanism is independently detectable in urinary metabolite panels [5].

Aerobic Exercise: The Fat-Loss Pathway

Adipose tissue is the primary extra-gonadal site of aromatase (CYP19A1) activity in both men and postmenopausal women [6]. Excess adipose tissue amplifies 16-OHE1 production by increasing substrate availability and aromatase gene expression. Losing fat mass directly lowers this substrate load.

Sturgeon et al. (2010, N=391 postmenopausal women) randomized participants to a 12-month aerobic exercise intervention (225 min/week at 60-80% VO2max) versus a stretching control. Fat mass loss of 1 kg was associated with a 0.38-unit increase in the 2-OHE1:16-OHE1 ratio (P<0.001) independent of total estrogen output [7]. Women who lost more than 3 kg fat mass saw a 1.1-unit mean ratio increase.

Aerobic Exercise: The CYP1A1 Induction Pathway

Regular aerobic activity upregulates the aryl hydrocarbon receptor (AhR) signaling cascade, which controls CYP1A1 transcription in hepatocytes and intestinal epithelium [8]. Increased CYP1A1 capacity preferentially hydroxylates estrone at the 2-position rather than the 16-position, shifting the metabolite balance within weeks.

McTiernan et al. (ALPHA trial, N=173) found that 12 months of moderate-intensity aerobic exercise (45 min/day, 5 days/week) raised urinary 2-OHE1 excretion by 18% and reduced 16-OHE1 by 11% in overweight postmenopausal women (P<0.05 for both) [9]. The effect was attenuated in women who did not achieve fat loss, supporting the view that CYP1A1 induction and adipose reduction are additive rather than redundant.

Exercise Intensity and Metabolite Response

Not all exercise intensities produce the same metabolite pattern. A cross-sectional study by Bélanger et al. (N=104) comparing sedentary women with moderate exercisers (3-4 hours/week) and competitive endurance athletes found a dose-response relationship: mean 2-OHE1:16-OHE1 ratios were 1.4, 2.3, and 2.9 respectively [10]. High-volume endurance athletes also showed lower total estrogen output, a finding consistent with HPA-axis mediated suppression of ovarian estradiol at very high training loads.

Conversely, acute high-intensity interval training (HIIT) transiently raises cortisol and may blunt the post-exercise estrogen ratio improvement seen with steady-state work. Data from Hackney et al. Showed acute cortisol spikes above 700 nmol/L correlate with transient suppression of CYP1A1 mRNA in peripheral blood mononuclear cells [11]. This is one reason optimal collection timing recommends avoiding intense exercise within 24 hours of specimen collection.

Resistance Training and Androgen Metabolites

Resistance training produces a distinct metabolite signature. The primary urinary androgen changes are increases in testosterone glucuronide, androsterone, and etiocholanolone, reflecting elevated testosterone synthesis and 5-alpha/5-beta reductase activity [12].

Testosterone Glucuronide Output

A 16-week progressive resistance training study by West et al. (N=56 men, ages 18-35) documented a 23% rise in 24-hour urinary testosterone glucuronide excretion at week 16 compared with baseline, with no significant change in serum total testosterone [13]. Urinary metabolite panels thus detect androgen pathway upregulation that serum spot tests miss.

DHEA-S and Adrenal Androgen Output

Resistance training also modestly raises DHEA-S in both men and postmenopausal women. Villareal and Holloszy (N=65, 6-month progressive resistance training) found mean DHEA-S increased by 18% in previously sedentary adults over 65 [14]. Because DHEA-S is an androgen precursor that feeds into estrogen synthesis via aromatization, this finding connects androgen training adaptation back to estrogen metabolite ratios, particularly in postmenopausal women with low ovarian output.

5-Alpha Reductase Activity Markers

Urinary androsterone:etiocholanolone ratios reflect the balance between 5-alpha and 5-beta reductase activity. Resistance-trained men show androsterone predominance compared with sedentary controls, consistent with greater 5-alpha reductase activity in skeletal muscle [15]. This ratio can shift within 8 weeks of structured resistance training.

Optimal Ranges for Urinary Sex Steroid Metabolites

Defining "optimal" requires separating reference intervals (population norms) from functional targets (ranges associated with favorable clinical outcomes).

Reference Intervals by Sex and Menopausal Status

Reported reference intervals vary by laboratory and collection method. For 24-hour urine by LC-MS/MS in premenopausal women (mid-luteal phase):

• 2-OHE1: 2.0-12.0 mcg/24h
• 16-OHE1: 1.0-6.0 mcg/24h
• 2-OHE1:16-OHE1 ratio: 1.0-4.5
• 4-OHE1: typically <10% of total hydroxylated estrogens

In postmenopausal women:

• 2-OHE1: 0.5-3.5 mcg/24h
• 16-OHE1: 0.3-2.0 mcg/24h
• 2-OHE1:16-OHE1 ratio: 0.8-4.0

Absolute values drop substantially after menopause; the ratio is therefore more clinically informative than absolute metabolite levels in this group [16].

Functional Targets from Longevity and Integrative Medicine Consensus

The following framework synthesizes current evidence into actionable lab targets. These are not FDA-cleared diagnostic cutoffs; they represent the ranges at which observational and intervention data converge toward favorable outcomes:

| Metabolite or Ratio | Functional Target | Clinical Concern Threshold | |---|---|---| | 2-OHE1:16-OHE1 ratio | Greater than 2.0 | Below 1.5 in premenopausal; below 1.0 in postmenopausal | | 4-OHE1 as % of total OHE | Below 10% | Above 15% (DNA adduct risk) | | 2-MeOE1:2-OHE1 ratio | Greater than 0.5 (COMT sufficiency) | Below 0.3 | | Androsterone:etiocholanolone | 0.8-2.5 | Above 3.5 (excess 5-alpha reductase) | | Total estrogen excretion (postmenopause) | 1.0-5.0 mcg/24h | Above 8.0 mcg/24h |

The 2-MeOE1:2-OHE1 ratio deserves attention because it measures how efficiently 2-OHE1 is methylated by COMT before it can be oxidized to the reactive 2,3-semiquinone. A ratio below 0.3 suggests COMT insufficiency or methylation cofactor depletion (B12, folate, magnesium) [17]. Exercise does not directly raise COMT activity, but it improves insulin sensitivity and reduces oxidative stress, both of which support methylation pathway efficiency.

The AACE and Endocrine Society Position on Metabolite Testing

The Endocrine Society's 2023 clinical practice guidelines on menopausal hormone therapy do not currently endorse routine urinary metabolite panel monitoring as a standard of care, noting that "current evidence does not support metabolite ratios as validated surrogate endpoints for breast cancer risk reduction" [18]. The American Association of Clinical Endocrinology (AACE) similarly treats these panels as supplementary rather than primary tests [19]. This does not mean the tests lack utility; it means their clinical role is in personalized hormone management rather than population screening.

Training Variables That Most Reliably Move the Ratio

Not all exercise types produce equal metabolite shifts. Ranking by evidence quality and effect size:

1. Sustained Aerobic Exercise with Fat Loss (Highest Impact)

The combination of aerobic exercise achieving fat loss of 3% or more of body weight consistently raises the 2-OHE1:16-OHE1 ratio by 0.5-1.5 units in controlled trials [7, 9]. Duration matters more than intensity at moderate loads. Three to five sessions per week at 55-75% VO2max for at least 12 weeks produces detectable shifts in most women.

2. Progressive Resistance Training (Moderate Androgen Impact, Modest Estrogen Ratio Effect)

Resistance training raises androgen metabolite output reliably but produces smaller estrogen ratio improvements unless accompanied by fat loss [13]. A 2019 meta-analysis by Kyröläinen et al. (17 trials, N=612) found mean 2-OHE1:16-OHE1 ratio improvements of 0.22 units from resistance training alone versus 0.91 units from aerobic training programs that achieved greater than 2 kg fat loss [20].

3. Combined Training (Best Overall Profile)

A 6-month combined aerobic plus resistance training intervention in overweight women (N=87, Friedenreich et al.) produced mean 2-OHE1:16-OHE1 ratio gains of 1.3 units, the largest single-arm change reported in any prospective trial to date [21]. The combined group also showed the greatest DHEA-S increase and the best COMT ratio improvement.

4. High-Volume Endurance Training Without Adequate Fueling (Risk of Hypoestrogenism)

Women training more than 12 hours per week without adequate caloric intake risk relative energy deficiency in sport (RED-S), which suppresses total estrogen production [22]. Urinary panels in this scenario show low absolute 2-OHE1 and 16-OHE1 values with a deceptively normal or elevated ratio. The ratio alone does not distinguish healthy 2-OH predominance from globally suppressed estrogen output. Total estrogen excretion must be interpreted alongside the ratio [23].

How to Time Testing Around Exercise

Specimen collection timing matters. Acute exercise transiently raises total urinary estrogen and androgen metabolite output, complicating baseline interpretation.

Key collection guidelines based on published pharmacokinetic data:

• Avoid strenuous exercise for at least 24 hours before collection [24].
• Collect a first-morning void or 24-hour urine per laboratory protocol; dried urine (DUTCH) uses four timed voids throughout the day.
• For cycle-phase accuracy in premenopausal women, collect on days 19-22 of a 28-day cycle (mid-luteal phase), per the Precision Analytical DUTCH reference protocol [25].
• Consistent hydration matters. Dehydration concentrates all urinary analytes; the lab will report creatinine-corrected values, but extreme dehydration from endurance training can still distort results.

If a patient is actively in a 12-week training block, the baseline panel should be drawn before the program starts and the follow-up panel collected after a 48-hour exercise taper.

Dietary and Lifestyle Interactions with the Exercise Effect

Exercise does not act in isolation. Several dietary factors modify the same enzymatic pathways and either amplify or blunt the training-driven metabolite shift.

Cruciferous Vegetables and Indole-3-Carbinol

Indole-3-carbinol (I3C), found in broccoli, cauliflower, and Brussels sprouts, induces CYP1A1 via the AhR pathway and raises the 2-OHE1:16-OHE1 ratio by 0.3-0.7 units in controlled supplementation studies [26]. The exercise-induced CYP1A1 upregulation and I3C-induced upregulation appear additive in the one trial that has tested both together (Michnovicz et al., N=47) [27].

Alcohol

Alcohol suppresses CYP1A1-mediated 2-hydroxylation and preferentially routes estrogen toward 16-OHE1 [28]. Even moderate alcohol intake (one drink per day) may partially offset the 2-OHE1 benefit of a structured exercise program. A cross-sectional analysis from the Women's Health Initiative (N=1,469) found that women consuming more than 7 drinks per week had 2-OHE1:16-OHE1 ratios 0.4 units lower than non-drinkers after adjusting for BMI and exercise [29].

Body Composition Beyond Fat Mass

Muscle mass independently predicts androgen precursor availability and DHEA-S output. Higher lean mass correlates with higher urinary androsterone and better COMT function in cross-sectional data [30]. This is an argument for prioritizing body composition over simple body weight reduction when interpreting metabolite trends.

Interpreting a Urinary Metabolite Panel in an Active Patient

A clinician reviewing a urinary sex steroid metabolite panel for a patient who exercises regularly should check these five elements:

1. Total estrogen output: Is it within physiological range for sex and menopausal status? Very low values in a hard-training woman raise RED-S concern.
2. 2-OHE1:16-OHE1 ratio: Is it above 2.0? If not, the exercise volume or dietary co-factors may be insufficient.
3. 4-OHE1 fraction: Above 15% of hydroxylated estrogens warrants attention regardless of exercise status [31].
4. 2-MeOE1:2-OHE1 ratio (COMT efficiency): Below 0.3 suggests a methylation bottleneck that exercise alone will not fix; B12, methylfolate, or magnesium supplementation may help.
5. Androgen metabolite pattern: Rising urinary testosterone glucuronide and DHEA-S after a resistance training program confirm expected adaptation and provide a compliance biomarker [32].

The Endocrine Society notes that "measuring steroid hormone metabolites in urine by mass spectrometry provides important information on steroidogenesis, metabolism, and excretion that serum hormone measurements cannot capture" [33].

A single panel has limited value. Serial testing at 12-week intervals during a structured training intervention generates the trend data needed to distinguish real physiological change from pre-analytical noise.